Altimmunes GLP-1 agonist in the clinic Some biotechs think that by broadening the therapeutic scope of GLP-1 agonists, cardiovascular diseases can be addressed
Benge weighs in on this, saying more research is to be done to determine if theyre worth it: If drops offer comparable results to pills or injectables with added convenience, they may gain traction, she says
Titration Phase: The dose increases in small steps (usually 5 mg, 7.5 mg, 10 mg, and beyond) depending on tolerance
Keep in mind that your healthcare team can provide guidance on potential financial assistance programs or options that may be available to help manage the cost of the medication
FDA Approval for Non-Diabetics: Currently, the FDA has not approved Ozempic for obesity, although some healthcare providers may prescribe it off-label for this use
What do I do if I accidentally took two doses of Ozempic